Definition: The Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant stands for a vaccine containing three different human papillomavirus types: Type 6, Type 11, and Type 16. Type 6 is the most commonly known type of HPV that can cause cancer. It is the only type that causes cervical cancer in women. Type 11 is a rare but potentially dangerous type of HPV that has been identified in males. It also causes cervical cancer in men, but it is less common and not as harmful. Type 16 is also a rare type of HPV that can cause genital warts (kinky cell carcinoma) in males, but this is considered to be less serious than Type 6 or 11, and only rarely seen in men. When the vaccine contains these types, it provides protection against all three types of HPV. This means that the immune system will be able to fight off the disease caused by each type of HPV if the person contracts it again. The Recombinant version of the vaccine is designed so that the different types of HPV are combined in a way that works best for preventing cancer and preventing infection, rather than simply being treated with one type. This means that the vaccine has been modified to specifically target and neutralize all three forms of HPV. Overall, the Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant is a way to prevent cancer caused by any type of HPV. It uses different types of HPV in combination to provide protection against multiple types, and it has been designed to be effective in preventing infection as well as preventing cancer.

Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant